COVID Quarantine Affects Glaucoma Compliance
Coconut Telegraph
SRQ DAILY FRESHLY SQUEEZED CONTENT EVERY MORNING
THURSDAY JUL 9, 2020 |
COVID has been hard on everyone, but especially those that depend on medications. The principal treatment for glaucoma has always been the use of eye drop medications. But that treatment only works if the patient adheres to a strict schedule of expensive eyedrops. Not being able to get those drops can be frightening; thinking that without them, you could lose your sight. This has been especially true for nursing home patients and those in quarantine.
For the first time, they are now able to inject a very tiny pellet of medication into the eye as an office based procedure. “I worry about my patients getting and using their glaucoma drops during COVID quarantine. By giving a simple administration of Durysta at the slit lamp, we are able to not only control the intraocular pressure for up to two years without drops but also be assured that the patient is getting the medication they need even when they can’t get to the pharmacy. This long-awaited treatment method Is extremely revolutionary and will save vision.” commented Dr. Friedman.
« View The Thursday Jul 9, 2020 SRQ Daily Edition
« Back To SRQ Daily Archive